IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

TORRENTE, YVAN
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 18.645
NA - Nord America 15.059
AS - Asia 12.614
SA - Sud America 1.448
AF - Africa 326
OC - Oceania 61
Continente sconosciuto - Info sul continente non disponibili 20
Totale 48.173
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.491
GB - Regno Unito 5.715
CN - Cina 4.551
SG - Singapore 3.658
IT - Italia 3.067
DE - Germania 2.918
SE - Svezia 1.847
RU - Federazione Russa 1.356
HK - Hong Kong 1.138
BR - Brasile 1.058
IN - India 848
NL - Olanda 684
TR - Turchia 634
UA - Ucraina 628
IE - Irlanda 557
FR - Francia 552
KR - Corea 545
FI - Finlandia 441
CA - Canada 435
EU - Europa 332
VN - Vietnam 297
ID - Indonesia 243
PL - Polonia 219
JP - Giappone 184
CO - Colombia 181
CI - Costa d'Avorio 162
DK - Danimarca 121
BE - Belgio 89
GR - Grecia 88
MX - Messico 80
AR - Argentina 75
BD - Bangladesh 67
CH - Svizzera 66
ES - Italia 58
IR - Iran 54
AU - Australia 52
AT - Austria 50
IQ - Iraq 48
UZ - Uzbekistan 47
TW - Taiwan 37
EC - Ecuador 36
RO - Romania 36
ZA - Sudafrica 33
PK - Pakistan 31
CZ - Repubblica Ceca 30
IL - Israele 29
MA - Marocco 29
VE - Venezuela 29
PH - Filippine 24
SA - Arabia Saudita 23
TH - Thailandia 22
PY - Paraguay 21
EG - Egitto 20
MY - Malesia 20
KE - Kenya 19
PT - Portogallo 19
CL - Cile 18
AE - Emirati Arabi Uniti 15
PE - Perù 14
AZ - Azerbaigian 12
JO - Giordania 12
KZ - Kazakistan 12
AL - Albania 11
DZ - Algeria 11
JM - Giamaica 11
LB - Libano 11
LT - Lituania 11
NO - Norvegia 11
SC - Seychelles 11
LU - Lussemburgo 10
BG - Bulgaria 9
UY - Uruguay 9
NZ - Nuova Zelanda 8
SK - Slovacchia (Repubblica Slovacca) 8
TN - Tunisia 8
TT - Trinidad e Tobago 8
BO - Bolivia 7
HR - Croazia 7
NP - Nepal 7
BH - Bahrain 6
KG - Kirghizistan 6
DO - Repubblica Dominicana 5
HU - Ungheria 5
LK - Sri Lanka 5
LY - Libia 5
PA - Panama 5
PS - Palestinian Territory 5
SI - Slovenia 5
XK - ???statistics.table.value.countryCode.XK??? 5
AO - Angola 4
BB - Barbados 4
BY - Bielorussia 4
CR - Costa Rica 4
LV - Lettonia 4
NG - Nigeria 4
QA - Qatar 4
RS - Serbia 4
IS - Islanda 3
MD - Moldavia 3
MK - Macedonia 3
Totale 48.428
Salva come PNG Salva come JPEG
Città #
Southend 5.228
Singapore 1.995
Ashburn 1.417
Chandler 1.206
Hong Kong 1.079
Beijing 1.052
Milan 1.001
Seattle 971
Frankfurt am Main 744
Princeton 733
Dallas 713
Wilmington 673
Dublin 549
Fairfield 530
Council Bluffs 460
Jacksonville 438
Mountain View 402
Redmond 369
Ann Arbor 357
Bengaluru 349
Nanjing 325
Hanover 319
Los Angeles 315
Munich 301
Woodbridge 297
Toronto 275
Santa Clara 262
Houston 244
Boardman 225
Des Moines 225
Sakarya 217
Buffalo 214
Dearborn 206
Phoenix 191
Cambridge 185
Warsaw 183
Moscow 182
Medford 167
Hefei 166
Abidjan 161
Serra 160
Jakarta 154
Guangzhou 149
Bogotá 148
Shanghai 145
Andover 142
Columbus 130
New York 124
Shenyang 120
Helsinki 119
São Paulo 117
Jinan 111
Nanchang 108
Somerville 104
Tokyo 100
Rome 98
Changsha 97
Eitensheim 96
Tianjin 94
Redwood City 93
Sunnyvale 89
Berlin 86
Cangzhou 85
Athens 78
Hebei 76
London 73
San Diego 73
Nuremberg 71
Brussels 70
Ho Chi Minh City 70
The Dalles 68
Fuzhou 67
Istanbul 67
Turin 64
Chicago 59
Zhengzhou 58
Hangzhou 57
Hamburg 53
Hanoi 53
Seoul 53
Bitonto 52
Portici 50
Odernheim 48
Ottawa 46
Roxbury 40
Kiez 39
Quanzhou 39
Mumbai 37
Boston 36
Jiaxing 35
Shenzhen 35
Atlanta 31
Falls Church 31
Kunming 31
Montreal 31
Ningbo 31
Wuhan 31
Auburn Hills 29
Rio de Janeiro 29
Norwalk 28
Totale 29.434
Salva come PNG Salva come JPEG
Nome #
Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models 409
24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy 344
Inositol 1,4,5-trisphosphate (IP3)-dependent Ca2+ signaling mediates delayed myogenesis in Duchenne muscular dystrophy fetal muscle 329
Effect of myofibril architecture on the active contraction of dystrophic muscle. A mathematical model 329
Purkinje cell COX deficiency and mtDNA depletion in an animal model of spinocerebellar ataxia type 1 327
CD133+ cells isolated from various sources and their role in future clinical perspective 314
Outcome measures validation study for mesoangioblasts transplantation in children affected by Duchenne Muscular Dystrophy 308
Modificazione genica di cellule staminali distrofiche allo scopo di trapianto autologo nella distrofia muscolare di Duchenne 294
Blockade of IGF2R improves muscle regeneration and ameliorates Duchenne muscular dystrophy 279
Allo-trapianto di mesoangioblasti da donatore hla-identico per la terapia cellulare della distrofia muscolare di Duchenne 260
Impaired Angiogenic Potential of Human Placental Mesenchymal Stromal Cells in Intrauterine Growth Restriction 260
A Special Amino-Acid Formula Tailored to Boosting Cell Respiration Prevents Mitochondrial Dysfunction and Oxidative Stress Caused by Doxorubicin in Mouse Cardiomyocytes 255
DIS3 depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplification 244
Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy 243
T and b lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse 239
Preliminary evidences of safety and efficacy of flavonoids- and omega 3-based compound for muscular dystrophies treatment: a randomized double-blind placebo controlled pilot clinical trial. 239
Induction of neurotrophin expression via human adult mesenchymal stem cells : implication for cell therapy in neurodegenerative diseases 238
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins 237
P(NIPAAM-co-HEMA) thermoresponsive hydrogels : an alternative approach for muscle cell sheet engineering 236
Immortalizzazione reversibile e trasduzione di mesoangioblastidmd con un cromosoma artificiale esprimente la distrofina per la terapia cellulare della distrofia muscolare 233
Supplementation with a selective amino acid formula ameliorates muscular dystrophy in mdx mice. 233
Long term natural history data in ambulant boys with duchenne muscular dystrophy: 36-month changes 231
Autologous intramuscular transplantation of engineered satellite cells induces exosomemediated systemic expression of Fukutin-Related Protein and rescues disease phenotype in a murine model of Limb-Girdle Muscular Dystrophy Type 2I. 230
Combined effects of nutrients and gut microbiota in the immunomodulation of DMD 230
Expression of CD20 reveals a new store-operated calcium entry modulator in skeletal muscle 229
6 minute walk test in duchenne MD patients with different mutations : 12 month changes 227
Stem cell–mediated transfer of a human artificial chromosome ameliorates muscular dystrophy 223
Characterization of muscle-specific expression of miRNAs in duchenne muscular dystrophy 221
Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients 220
Rest is required for the regenerative response of skeletal muscle 220
Exome sequencing identifies variants in two genes encoding the LIM-proteins NRAP and FHL1 in an Italian patient with BAG3 myofibrillar myopathy 220
High Mobility group protein 3 (Hmgb3) is regulated by microRNA-206 during muscle regeneration 218
Ruolo delle cellule staminali di derivazione cutanea nella rigenerazione assonale delle lesioni della 'dorsal root entry zone' midollare 215
Stop codons, duplicazioni e delezioni: caratterizzazione genetica e follow-up clinico in una coorte di 201 pazienti affetti da distrofia Muscolare di Duchenne 215
Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation 212
Skin-derived stem cells transplanted into resorable guides provide functional nerve regeneration after sciatic nerve resection 212
Correlation of circulanting CD133+ progenitor subclasses with a Mild phenotype in Duchenne Muscular dystrophy patients 211
Morphological modifications of resected sciatic nerve after autologous transplantation of skin-derived stem cells into resorable guides. 210
Combining Stem Cell and Exon Skipping Approach to Treat Muscular Dystrophies 209
Stem cells and muscular dystrophies 208
Advancements in stem cells treatment of skeletal muscle wasting 208
Fate of autologous dermal stem cells transplanted into the spinal cord after traumatic injury (TSCI) 206
Autologous transplantation of skin-derived stem cells and functional nerve regeneration after a peripheral nerve lesion 204
Fibrin gels engineered with pro-angiogenic growth factors promote engraftment of pancreatic islets in extrahepatic sites in mice 203
Heterogeneous tumorigenic capacity of human brain tumor derived neurospheres 200
Abundance of circulating progenitors with myo-endothelial potential correlates with a mild phenotype in patients affected by Duchenne muscular dystrophy 199
Miopatia progressiva con ptosi, oftalmoplagia e aspetti distrofici alla biopsia muscolare 199
Interstitial Cell Remodeling Promotes Aberrant Adipogenesis in Dystrophic Muscles. 199
Ruolo delle iPS nella medicina personalizzata 197
Quantitative muscle strength assessment in Duchenne muscular dystrophy: longitudinal study and correlation with functional measures 196
Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin‐deficient mice 193
VCAM-1 expression on dystrophic muscle vessels has a critical role in the recruitment of human blood-derived CD133+ stem cells after intra-arterial transplantation 193
Heterogeneous tumourogenic ability of human brain tumour derived neurospheres 193
CD20-related signaling pathway is differently activated in normal and dystrophic circulating CD133+ stem cells 192
Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up 192
Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy 192
Generation of the Becker muscular dystrophy patient derived induced pluripotent stem cell line carrying the DMD splicing mutation c.1705-8 T>C 192
Therapeutic Potential of Immunoproteasome Inhibition in Duchenne Muscular Dystrophy 191
Functional and structural modifications of dystrophic muscles after autologous transplantation of muscle-derived AC133+ stem cells 190
Polyglycolic acid–polylactic acid scaffold response to different progenitor cell in vitro cultures : a demonstrative and comparative x-ray synchrotron radiation phase-contrast microtomography study 190
Il trapianto di cellule staminali autologhe derivate da cute in guide tubolari riassorbibili favorisce la rigenerazione assonale nelle lesioni del nervo periferico 188
Bank of DNA, cell lines and nerve-muscle-cardiac tissues 186
Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model 186
Autologous transplantation of AC133+ stem cells in Duchenne muscular Dystrophy : preclinical and clinical evidences 184
Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells 183
Heterogeneous tumorigenic capacity of human brain tumor derived neurospheres 183
Some applications of nanotechnologies in stem cells research 182
Autologous transplantation of bone marrow-derived CD133+ stem cells in facioscapulohumeral dystrophy 182
Abundance of circulating progenitors with myo-endothelial potential correlates with a mild phenotype in patients affected by Duchenne muscular dystrophy 179
In vitro and in vivo tetracycline-controlled myogenic conversion of NIH-3T3 cells : Evidence of programmed cell death after muscle cell transplantation 179
Difference in myogenic properties of the blood-derived AC133+ stem cells subpopulation isolated from normal and dystrophic tissues 177
Il trapianto di Mioblasti nelle Miopatie ereditarie 177
Erratum: (Journal of Cell Biology (July 17, 2006) 174:2 (231-243)) 176
Therapeutic Potential of Immunoproteasome Inhibition in DMD 176
Autologous transplantation of AC133+ stem cells in Duchenne muscular Dystrophy : preclinical and clinical evidences 175
Blood-derived CD133+ stem cells from normal and dystrophic tissues: a comparative study with clinical applications 174
Cellule staminali e rigenerazione muscolare 174
Cell Therapy of Muscular Dystrophy with Engineered CD133+ Cells 174
Stem Cell Salvage of injured peripheral nerve 174
Topical Treatment of Radiation-Induced Dermatitis: Current Issues and Potential Solutions 174
Myogenic potential of human circulating AC133+ stem cells in murine dystrophic skeletal muscle 173
AAV6-mediated systemic shRNA delivery reverses disease in a mouse model of facioscapulohumeral muscular dystrophy 173
5'azacytidine enhances exogenous gene expression in muscle 173
Development of a new technique for muscle tissues-stem cells co-colture 173
Stem cell-mediated exon skipping of the dystrophin gene by the bystander effect 173
Le cellule staminali come approccio terapeutico della paralisi cerebrale infantile 172
Immortalized skin fibroblasts expressing conditional MyoD as a renewable and reliable source of converted human muscle cells to assess therapeutic strategies for muscular dystrophies: Validation of an exon-skipping approach to restore dystrophin in duchenne muscular dystrophy cells 171
Cell Theraphy of Muscolar Dystrophy with Engineered CD133+Cell 171
Impact of Muscular Dystrophy on the Regenerative Properties of interstitial Muscle Cells 171
Defective dystrophic thymus determines degenerative changes in skeletal muscle 171
Human skin-derived stem cells inhibit brain tumor growth 170
Congenital myopathy with ptosis, ophthalmoplegia and muscle dystrophic changes: a possible sporadic case of myosin heavy chain type IIa myopathy. 170
Perspectives of Stem Cell Therapy in Duchenne Muscular Dystrophy 170
Human fetal CD133+ skeletal muscle cells expressing pericyte merkers generate muscle and endothelial cells and repair dystrophic muscle tissues. 169
Encefalomiopatie mitocondriali. Simposi in Medicina Clinica. Rivista Medica degli Ospedali di Milano IRCCS Ospedale Maggiore di Milano, Niguarda Cà Granda, San Carlo Borromeo e di Sesto S. Giovanni. The role of Molecular genetics in neurological diagnosis. Masson 89, (2): 177-186, 1995 169
Stem cells in muscle diseases 169
MICAL2 is essential for myogenic lineage commitment. 169
Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy : an Observational Study 168
Treatment with ROS detoxifying gold quantum clusters alleviates the functional decline in a mouse model of Friedreich ataxia 168
MicroRNA-206 is upregulated in an animal model of Duchenne Muscular Distrophy 167
Totale 20.933
Salva come PNG Salva come JPEG
Categoria #
all - tutte 142.782
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 142.782
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.674 0 0 0 0 0 232 315 236 434 241 979 237
2021/20224.168 264 216 133 250 279 308 314 218 583 323 400 880
2022/20235.305 757 521 450 509 597 939 175 363 593 105 198 98
2023/20243.390 124 235 176 198 858 213 198 190 114 239 345 500
2024/20258.098 343 801 208 942 587 327 389 836 397 728 682 1.858
2025/20267.591 1.701 1.084 1.749 1.411 1.542 104 0 0 0 0 0 0
Totale 50.753